What is Different About Daxxify Compared to Botox?

Daxxify is one of the newest neurotoxins on the market. It is unique in that it is the first neurotoxin to be released with extended treatment effectiveness. Daxiffy is FDA-approved to smooth moderate to severe lines between the brows for six to nine months.

The increased duration time of Daxxify compared to Botox, Dysport, Jeuveau, and Xeomin is why patients and plastic surgeons are so excited. While the other neurotoxins that have come on the market since Botox did over twenty years ago have all had unique properties, none have increased the effective treatment time.

Daxxify is a botulinum toxin type A neurotoxin similar to Botox and Dysport. Daxxify was designed with a novel peptide that helps stabilize the neurotoxin. This stabilization leads to the longer effective action of Daxxify over other neurotoxins such as Botox and Dsyport. However, all of these products have a different surrounding peptide.

Daxxify, a botulinum toxin type A neurotoxin, will allow providers to use Daxxify in similar locations and treat similar patient concerns. However, patients will be able to have a result that will typically last six to nine months. This will allow patients to decrease their office visits in half for their treatments per year. In the past, patients would come to the office three to four times a year for their Botox or Dysport treatment. Patients can now come twice a year and maintain their aesthetic results after treatment with Daxxify.

Please discuss with your Board-Certified Plastic Surgeon if Daxxify would be a good option for you to treat your fine lines and wrinkles.

  • Share: